Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to $184.3 million.

  • CV Sciences' Shares Outstanding (Weighted Average) rose 109.9% to $184.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $184.3 million, marking a year-over-year increase of 109.9%. This contributed to the annual value of $138.0 million for FY2022, which is 2802.62% up from last year.
  • As of Q3 2025, CV Sciences' Shares Outstanding (Weighted Average) stood at $184.3 million, which was up 109.9% from $184.3 million recorded in Q2 2025.
  • In the past 5 years, CV Sciences' Shares Outstanding (Weighted Average) registered a high of $184.3 million during Q1 2025, and its lowest value of $104.5 million during Q1 2021.
  • Over the past 5 years, CV Sciences' median Shares Outstanding (Weighted Average) value was $152.1 million (recorded in 2023), while the average stood at $146.8 million.
  • In the last 5 years, CV Sciences' Shares Outstanding (Weighted Average) skyrocketed by 3428.95% in 2022 and then surged by 109.9% in 2025.
  • Quarter analysis of 5 years shows CV Sciences' Shares Outstanding (Weighted Average) stood at $107.8 million in 2021, then rose by 28.03% to $138.0 million in 2022, then grew by 12.0% to $154.6 million in 2023, then increased by 17.89% to $182.3 million in 2024, then grew by 1.1% to $184.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $184.3 million for Q3 2025, versus $184.3 million for Q2 2025 and $184.3 million for Q1 2025.